HomeNewsBusinessEconomyBurden of taxes impeding household consumption: Ind Ra study

Burden of taxes impeding household consumption: Ind Ra study

Unlike the corporates who are enjoying a rationalisation in income tax, no such move has been introduced for the households who continue paying elevated taxes.

June 08, 2021 / 15:36 IST
Story continues below Advertisement
Representative image
Representative image

The burden of taxation, particularly indirect taxes, on households has worsened lately and is preventing them from spending more on consumption, a domestic rating agency said on Tuesday. Unlike the corporates who are enjoying a rationalisation in income tax, no such move has been introduced for the households who continue paying elevated taxes, it said.

Burden on households tax could delay consumption recovery, India Ratings and Research warned, stating that the increase in indirect taxes through the excise duty hike in fuels just before the pandemic and the second wave of infections have had an impact. The share of total tax burden on households has risen to 75 per cent from 60 per cent in FY10, it said, explaining that this was largely due to the combination of a higher excise duty on fuel and a reduction in corporate tax.

Story continues below Advertisement

Second COVID-19 wave will have material impact on vehicle financers’ asset quality: Ind-Ra study

It said corporation tax has been rationalised to augment job creation and attracting direct foreign investments, and also backed the move calling it a legitimate change because it made our exports uncompetitive. "The burden of taxes, particularly of indirect taxes, on households has worsened lately, it said, adding that the excise hike has led to retail prices of petrol and diesel hitting record levels and impacting household budgets both directly and indirectly.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show